CAMBRIDGE NUTRITIONAL SCIENCES PLC Regulatory Story
Go to market news section Omega Diagnostics Group PLC - ODX Released 10:35 18-Jul-2017RNS Number : 3724L
Omega Diagnostics Group PLC 18 July 2017
Result of General Meeting
18 July 2017 Omega Diagnostics Group plc Result of General MeetingFurther to Omega's announcement of 30 June 2017, the Company is pleased to announce today the passing of the Resolutions at the General Meeting held earlier today. The Placing, Subscription and Open Offer remain conditional on Admission of the New Ordinary Shares to AIM which is expected to take place at 8.00 a.m. tomorrow.
With effect from Admission the Company will have 126,884,060 Ordinary Shares in issue, with no shares held in treasury. Shareholders may use this figure as the denominator by which they are required to notify their interest in, or change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.
Capitalised terms not otherwise defined in the text of this announcement have the meanings given to them in the Company's circular dated 30 June 2017.
Contacts: Omega Diagnostics Group PLCAndrew Shepherd, Chief Executive
Kieron Harbinson, Group Finance Director Jag Grewal, Group Sales and Marketing Director
Tel: 01259 763 030
www.omegadiagnostics.com
finnCap Ltd Tel: 020 7220 0500Geoff Nash/James Thompson (Corporate Finance)
Mia Gardner (Corporate Broking)
Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.comPaul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303
Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):
1. | Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA') | ||
a) | Name | David Evans | |
2. | Reason for notification | ||
b) | Position / status | Non-Executive Chairman | |
c) | Initial notification / amendment | Initial Notification | |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
b) | Name | Omega Diagnostics Group plc | |
c) | LEI | 2138007U9P4BTZTYIR92 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument Identification code | ordinary shares of 4p each GB00B1VCP282 | |
b) | Nature of the transaction | Acquisition of shares pursuant to the Placing | |
c) | Price(s) and volume(s) | ||
Price(s) | Volume(s) | ||
£0.18 | 1,111,111 | ||
d) | Aggregated information Aggregated volume Price | n/a | |
e) | Date of the transaction | 19 July 2017 | |
f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) | |
1. | Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA') | |
a) | Name | Andrew Shepherd |
2. | Reason for notification | |
b) | Position / status | Chief Executive Officer |
c) | Initial notification / | Initial Notification |
amendment | |||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
b) | Name | Omega Diagnostics Group plc | |
c) | LEI | 2138007U9P4BTZTYIR92 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument Identification code | ordinary shares of 4p each GB00B1VCP282 | |
b) | Nature of the transaction | Acquisition of shares pursuant to the Placing | |
c) | Price(s) and volume(s) | ||
Price(s) | Volume(s) | ||
£0.18 | 111,111 | ||
d) | Aggregated information Aggregated volume Price | n/a | |
e) | Date of the transaction | 19 July 2017 | |
f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) | |
1. | Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA') | |
a) | Name | Kieron Harbinson |
2. | Reason for notification | |
b) | Position / status | Finance Director |
c) | Initial notification / amendment | Initial Notification |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
b) | Name | Omega Diagnostics Group plc |
c) | LEI | 2138007U9P4BTZTYIR92 |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument | ordinary shares of 4p each |
Identification code | GB00B1VCP282 | ||
b) | Nature of the transaction | Acquisition of shares pursuant to the Placing | |
c) | Price(s) and volume(s) | ||
Price(s) | Volume(s) | ||
£0.18 | 55,555 | ||
d) | Aggregated information Aggregated volume Price | n/a | |
e) | Date of the transaction | 19 July 2017 | |
f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) | |
1. | Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA') | ||
a) | Name | Jag Grewal | |
2. | Reason for notification | ||
b) | Position / status | Sales & Marketing Director | |
c) | Initial notification / amendment | Initial Notification | |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
b) | Name | Omega Diagnostics Group plc | |
c) | LEI | 2138007U9P4BTZTYIR92 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument Identification code | ordinary shares of 4p each GB00B1VCP282 | |
b) | Nature of the transaction | Acquisition of shares pursuant to the Placing | |
c) | Price(s) and volume(s) | ||
Price(s) | Volume(s) | ||
£0.18 | 53,333 | ||
d) | Aggregated information | n/a | |
Omega Diagnostics Group plc published this content on 18 July 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 28 July 2017 14:04:03 UTC.
Original documenthttp://www.omegadiagnostics.com/Portals/0/170718 - Result of General Meeting - RNS - London Stock Exchange.pdf
Public permalinkhttp://www.publicnow.com/view/CA6F1C936FB8C98EB5ECAF0F2E7B2A8F97CAD45C
